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Abstract
Background: Nucleocytoplasmic transport is a tightly regulated process carried out by specific transport machinery,
the defects of which may lead to a number of diseases including cancer. Karyopherin alpha 7 (KPNA7), the newest
member of the karyopherin alpha nuclear importer family, is expressed at a high level during embryogenesis,
reduced to very low or absent levels in most adult tissues but re-expressed in cancer cells.
Methods: We used siRNA-based knock-down of KPNA7 in cancer cell lines, followed by functional assays (proliferation
and cell cycle) and immunofluorescent stainings to determine the role of KPNA7 in regulation of cancer cell growth,
proper mitosis and nuclear morphology.
Results: In the present study, we show that the silencing of KPNA7 results in a dramatic reduction in pancreatic
and breast cancer cell growth, irrespective of the endogenous KPNA7 expression level. This growth inhibition is
accompanied by a decrease in the fraction of S-phase cells as well as aberrant number of centrosomes and
severe distortion of the mitotic spindles. In addition, KPNA7 depletion leads to reorganization of lamin A/C and
B1, the main nuclear lamina proteins, and drastic alterations in nuclear morphology with lobulated and elongated
nuclei.
Conclusions: Taken together, our data provide new important evidence on the contribution of KPNA7 to the
regulation of cancer cell growth and the maintenance of nuclear envelope environment, and thus deepens our
understanding on the impact of nuclear transfer proteins in cancer pathogenesis.
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Background
Eukaryotic cells are compartmentalized to contain dis-
tinct organelles such as the nucleus. The separation of
the nucleus from the cytoplasm by the nuclear envelope
forms a barrier across which large macromolecules, such
as proteins, need to be transported. This allows the
physical separation of transcription events in the nucleus
and protein translation in the cytoplasm, thereby provid-
ing the cell an additional system for the regulation of
protein function [1, 2]. The nucleocytoplasmic transport
of proteins is carried out by specific transport machinery
where proteins are shuttled in and out of the nucleus
through the nuclear pore complexes (NPC) at the
nuclear envelope [3]. In the classical protein import, kar-
yopherin alpha (KPNA, also known as importin alpha)
recognizes the protein containing a nuclear localization
signal (NLS) [4–6]. The KPNA-cargo complex then
binds to karyopherin beta 1 (KPNB1, also known as
importin beta) that docks to the NPC and mediates the
transport to the nucleus, where the cargo is released
when the GTP-binding nuclear protein Ran (Ran-GTP)
binds to KPNB1 [6, 7].
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Defects in nuclear import, for instance due to abnormal
function of members of the nuclear transport machinery,
result in incorrect localization of proteins that might sub-
sequently lead to a diversity of diseases, including cancer
[1, 8–12]. For example, the tumor suppressor protein p53
has been shown to be inactivated in cancer due to a trun-
cated form of KPNA that was incapable of transporting
p53 into the nucleus, its proper location of action [13, 14].
Currently, the strongest evidence on the role of karyo-
pherins in cancer pathogenesis comes from studies on
KPNA2. KPNA2 is upregulated in a large variety of tumor
types and its elevated expression is associated with an
increased degree of malignancy, tumor spread and poor
patient outcome [15, 16]. KPNA2 overexpression is
already present in early lesions indicating that it is not
merely a marker of advanced disease but actively partici-
pates in the pathogenesis process [15]. This notion is sup-
ported by functional studies where enhanced KPNA2
expression leads to increased cell proliferation and migra-
tion [15]. Other KPNAs have also been implicated in can-
cer. For example, KPNA4 was recently shown to promote
the migration and metastatic potential of prostate cancer
cells [17]. These data illustrate that alterations in nuclear
transport are important players in cancer pathogenesis.
The karyopherins in the cells are vital to proper
nuclear transport but their functional roles are even
more diverse. They participate in the assembly of the
mitotic spindle where the duplicated chromosomes are
aligned during mitosis, and thereby ensure the fidelity of
cell division [18, 19]. Karyopherins bind the spindle
assembly factors (SAFs), keeping them inactive, and
release them in an appropriate location near mitotic
chromosomes thus preventing mislocalization of the
spindle [19]. The release of SAFs is regulated by the dif-
ferential concentration of Ran-GTP between the nucleus
and cytoplasm, which is maintained by guanine nucleo-
tide exchange factors (GEFs) in the nucleus and GTPase
activating proteins (GAPs) in the cytoplasm [20]. The
Ran-GTP gradient is also preserved around the chroma-
tin after the dissociation of the nuclear envelope during
mitosis [20]. Subsequent to chromosome separation, kar-
yopherins are also involved in the reassembly of the
nuclear envelope that consists of the inner and outer nu-
clear membranes and associated proteins, mainly lamins
and the NPC proteins [18, 19, 21].
The human karyopherin alpha family consists of seven
highly conserved members, with KPNA7 being the most
recently identified, divergent and least studied member
[22, 23]. KPNA7 is mainly expressed during early em-
bryogenesis and in oocytes in different animals [24–26]
and has been identified as one of the target genes for the
7q21-22 amplicon in pancreatic cancer [27]. However,
the precise function of KPNA7 in human cells remains
elusive. In our previous work we pinpointed KPNA7 as a
regulator of malignant properties in pancreatic cancer
cells with high KPNA7 expression [28]. Here we extend
these findings to show that even low KPNA7 expression
plays an important role in the proliferation of both pan-
creatic and breast cancer cells. Furthermore, our data
demonstrate that KPNA7 has a key role in the proper
formation of the mitotic spindle and in the maintenance
of nuclear morphology.
Methods
Cell lines
Hs700T, MIA PaCa-2 and SU.86.86 pancreatic cancer
cell lines; MCF-7, T-47D, MDA-MB-231 and MDA-MB-
453 breast cancer cell lines and hTERT-HPNE normal
pancreas epithelial cell line were purchased from the
American Type Culture Collection (ATCC, Manassas,
VA, USA). The cell lines were authenticated by genotyp-
ing and were grown under recommended culture condi-
tions. The cells were regularly tested for Mycoplasma
infection.
Gene expression analysis
Total RNA was extracted using RNeasy Mini kit (Qiagen,
Hilden, Germany). Quantitative real-time PCR (qRT-PCR)
was performed using the Roche LightCycler 2.0 instrument
(Roche, Mannheim, Germany) with LightCycler® TaqMan®
Master reaction mix (Roche). Universal Probe Library
(Roche) probes and associated primers (Sigma Aldrich, St
Louis, MO, USA) and Roche’s Reference Gene Assay for
HPRT was utilized for normalization. All primer and probe
sequences are listed in Additional file 1: Table S1.
Gene silencing
Four specific small interfering RNAs (siRNAs) against the
KPNA7 gene were designed using the siRNA Selection Pro-
gram of the Whitehead Institute, Cambridge, MA, USA
and the siRNAs were obtained from Dharmacon (Lafayette,
CO, USA). A pool containing an equal concentration of
each of the four siRNAs was prepared. SMAD5 SMART-
pool siRNA was acquired from Dharmacon. An siRNA
targeting the firefly luciferase (LUC) gene (Sigma Aldrich)
was used as a control in all transfections. Transfections
were performed either on 24-well or 6-well plates using
10 nM siRNA and Interferin reagent (Polyplus-Transfec-
tion, San Marcos, CA, USA) as described previously [27].
The efficacy of the gene silencing was verified in each ex-
periment using qRT-PCR. The number of cells plated per
experiment are listed in Additional file 1: Table S2.
Cell growth and cell cycle analysis
For cell proliferation assays, the cells were seeded (for cell
numbers see Additional file 1: Table S2) on a 24-well plate
and transfected with KPNA7 or LUC siRNAs as described
above. The cells were counted at 72 h or 96 h after
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transfection using a Coulter Z2 Coulter Counter (Beckman
Coulter, San Diego, CA, USA). In cell cycle studies, the
cells were seeded (for cell numbers see Additional file 1:
Table S2) on 6-well plates, transfected with KPNA7 or
LUC siRNAs and analyzed 96 h after transfection. The cells
were collected by trypsinization and suspended to 500 μL
hypotonic staining buffer (0.1 mg/mL sodium citrate tri-
basic dehydrate, 0.03% Triton X-100, 50 μg/mL propidium
iodide, 2 μg/mL RNase A) and the amount of propidium
iodide incorporated was determined using flow cytometry
(BD Accuri Cytometers, Ann Arbor, MI, USA). The cell
cycle distributions were determined using the ModFit LT
software (Verity Software House Inc., Topsham, ME,
USA). All experiments were performed in six replicates
and repeated at least twice.
Immunofluorescence assays
Immunofluorescence (IF) was used to assess the
localization of γ-tubulin, different nuclear envelope pro-
teins and formation of stress fibers. The cells were plated
on coverslips on 24-well plates (for cell number see
Additional file 1: Table S2) and the IF stainings were
performed as previously described [29]. The following
antibodies and dilutions were used: anti-lamin A/C 1:
200 (ab8984, Abcam, Cambridge, UK), anti-lamin B1 1:
500 (ab16048, Abcam), anti-NUP153 1:1000 (ab24700,
Abcam), anti-γ-tubulin 1:500 (ab179503, Abcam), anti-
phospho Myosin Light Chain 2 1:200 (#3674S, Cell Sig-
naling Technology, Danvers, MA, USA), Alexa Fluor
568 Phalloidin 1:200 (Molecular Probes, Eugene, OR,
USA) and Alexa Fluor secondary antibodies 1:200
(Molecular Probes). The samples were mounted in Pro-
Long Antifade Gold reagent with DAPI (Molecular
probes). The fluorescently labeled cells were photo-
graphed using the Zeiss Apotome or the Zeiss LSM 780
laser scanning confocal microscope (Zeiss, Oberkoche,
Germany).
Quantification of the IF data
A total of 50 mitotic cells from γ-tubulin stained,
siRNA treated cells were scored using the Zeiss Apo-
tome (40X objective) and classified either as normal
or abnormal based on the number of centrosomes
and the structure of the mitotic spindle. The appear-
ance of the nuclei was visually inspected from lamin
A/C images obtained using the confocal microscope
and a 40X objective. The nuclei were categorized as
normal or aberrant and their number was determined
from a minimum of six images. ImageJ software (US
National Institute of Health, Bethesda, MD, USA) was
used for the quantitation of the nuclear size and
shape as well as nuclear aspects ratios in 50 randomly
selected nuclei from samples stained with lamin A/C.
In the case of NUP153 staining, ImageJ was used for
the quantitation of the number of spots per nucleus.
Western blotting
Cell lysates were separated in a 7% (for NUP153) or 10%
(for lamins) SDS-PAGE gel. The proteins were transferred
onto polyvinylidene fluoride (PVDF) membrane (Roche)
using a tank blotter (NUP153 western) or Trans-Blot SD
semi-dry transfer cell (Bio-Rad Laboratories, Hercules,
CA, USA). The membrane was blocked with Blocking
Reagent (Roche) in tris-buffered saline (TBS, 50 mM Tris-
HCl, 150 mM NaCl, pH 7.5) for 1 h at RT. After blocking,
the membrane was probed with primary antibody diluted
in 3% BSA in 0.05% TBS-Tween-20 (TBST) overnight at
4 °C and subsequently with HRP-conjugated IgG second-
ary antibody (Vector Laboratories, Burlingame, CA, USA)
1:8000 in 0.05% TBST for 1 h at RT. The protein bands
were detected with Pierce™ ECL Plus Western Blotting
Substrate (ThermoFischer Scientific, Waltham, MA,
USA). The following antibodies and dilutions were
used: anti-lamin A/C 1:500 (ab2811, Abcam), anti-
lamin B1 1:1000 (ab16048, Abcam), anti-NUP153 1:
1000 (ab24700, Abcam) and anti-β-Tubulin 1:20,000
(T7816, Sigma-Aldrich).
Statistical analyses
The Mann-Whitney test was used to statistically com-
pare the means of the siKPNA7 and siLUC control
groups.
Results
KPNA7 is essential for pancreatic and breast cancer cell
proliferation
We previously showed that amplification and subse-
quent overexpression of KPNA7 leads to promotion of
cell growth in Hs700T and AsPC-1 pancreatic cancer
cell lines [28]. To obtain a more comprehensive view
on the functional role of this protein in cancer cells, we
extended these studies to include pancreatic (MIA
PaCa-2, SU.86.86) and breast (MCF-7, MDA-MB-231,
T-47D) cancer cell lines without KPNA7 amplification
and with varying levels of endogenous KPNA7 expres-
sion (Additional file 2: Figure S1). KPNA7 was silenced
in these cell lines as well as the Hs700T cells with siR-
NAs leading to a minimum of 80% decrease in mRNA
levels (Additional file 1: Table S3). As previously shown
[28], the silencing resulted in a dramatic reduction of
cell growth in Hs700T cells as compared to controls
transfected with siRNAs targeting the firefly luciferase
(LUC) gene (Fig. 1a). Likewise, the other pancreatic and
breast cancer cell lines exhibited statistically significant
decreases in proliferation after KPNA7 knock-down
(Fig. 1a, b). In fact, there was a minimal or no differ-
ence in Hs700T and T-47D cell numbers between the
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72 h and 96 h time points after transfection
(Additional file 3: Figure S2A) indicating that KPNA7
silencing leads to an actual growth arrest as cell
numbers do not change after 72 h. qRT-PCR was used
to confirm the KPNA7 knock-down in all time points
(Additional file 3: Figure S2B).
To confirm the specificity of the observed growth ef-
fect, the KPNA7 siRNAs were also transfected into both
normal (hTERT-HPNE) and cancerous (MDA-MB-453)
cells that completely lack KPNA7 expression (Additional
file 2: Figure S1) and no changes in cell growth were
observed (Fig. 1c). Since the efficacy of the KPNA7 siR-
NAs cannot be measured in these cells, parallel transfec-
tions with siRNAs against the SMAD5 gene were
performed and led to a 70% reduction in mRNA level,
thus indicating that the experimental conditions were
appropriate. To evaluate the possible mechanisms be-
hind the growth inhibition phenotype, cell cycle profiles
were determined in one breast and one pancreatic can-
cer cell line (T-47D and MIA PaCa-2, respectively) 96 h
after transfection with KPNA7 and LUC control siRNAs.
These analyses revealed that KPNA7 inhibition resulted
in a diminished fraction of proliferating S-phase cells,
with a concomitant increase in G2-phase cells (Fig. 2).
The fraction of sub-G1 cells was not altered (data not
shown). These results are in agreement with our previ-
ous data on Hs700T cells [28].
Correct assembly of the mitotic spindle is affected by
KPNA7 depletion
The growth arrest phenotype and altered cell cycle dis-
tributions of siKPNA7-treated cells led us to hypothesize
that mitosis is disturbed in these cells. To address this
issue, we studied the organization of centrosomes by
staining their major structural component γ-tubulin,
again in one pancreatic and one breast cancer cell line
96 h after transfection with KPNA7 and LUC control
siRNAs. Unfortunately, the MIA Paca-2 cells turned out
to grow in thick colonies partially on top of each other
and had very dense nuclei and thus they were hard to
Fig. 1 Silencing of KPNA7 inhibits cell proliferation in cells with
endogenous KPNA7 expression. KPNA7 was silenced with siRNAs in
(a) pancreatic and (b) breast cancer cell lines with different levels of
endogenous KPNA7 expression, as well as in (c) KPNA7-negative cell
lines. A siRNA targeting the firefly luciferase gene (LUC) was used as
a control. Mean cell numbers (± SD of six replicates) were determined
72 or 96 h post-transfection and normalized to the mean of siLUC
control of each cell line. The silencing efficiencies were verified in each
case with qRT-PCR and are shown in Additional file 1: Table S3.
The experiments were repeated at least twice and data from one
representative experiment is shown. *p < 0.05, **p < 0.01
Fig. 2 KPNA7 depletion results in reduced number of S-phase cells.
The cell cycle distributions were analyzed using flow cytometry 96 h
after transfection of siRNAs against KPNA7 or LUC control gene. The
experiment was repeated at least twice. The mean and SD of six
replicates from a representative experiment are shown.*p< 0.05, **p< 0.01
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image properly. Therefore, the Hs700T and T-47D cells
were used these and all subsequent experiments. The
number of centrosomes and the structure of the mitotic
spindles was normal, with two centrosomes at the op-
posite ends of the cell and chromatin aligned correctly
in the middle of the nucleus, in 100% and 98% of the
mitotic siLUC transfected Hs700T and T-47D control
cells, respectively (Fig. 3). In contrast, after KPNA7
silencing, 18% of mitotic Hs700T and 20% of mitotic T-
47D cells harbored an abnormal number of centrosomes
(Fig. 3). Typically, three to four centrosomes were ob-
served, leading to distortion of the mitotic spindle and
subsequent aberrant alignment of the chromatin.
KPNA7 silencing results in distinct changes in nuclear
morphology
Based on the DAPI-staining in the experiments described
above, we noted that the KPNA7-silenced interphase cells
had aberrant nuclear shape. To better visualize this effect,
the cells were stained for lamin A/C, the major compo-
nent of the nuclear lamina, revealing distinct lobular nu-
clear morphology in Hs700T cells (Fig. 4a). The
quantitation of the number of normal vs. aberrant nuclei
showed a dramatic increase in the fraction of abnormal
nuclei from 17% in the control cells to 86% in the
KPNA7-silenced cells (p < 0.01, Fig. 4b). The analysis of
nuclear size and shape showed that the siKPNA7-treated
Hs700T cells had significantly larger nuclei than the con-
trol cells (p < 0.01, Fig. 4f). The aspect ratio (calculated as
indicated in Additional file 4: Figure S3 both in XY and
YZ dimensions) of the nuclei in XY dimension was not af-
fected, but a significant increase in YZ aspect ratio was
observed (p < 0.005, Fig. 4f). These data indicate that in
Hs700T cells KPNA7 depletion leads to the flattening of
the nuclei, which was also visible in the cross-sectional
view of the nuclei (Fig. 4a). In T-47D cells, KPNA7 deple-
tion resulted in an elongated, distorted shape of the nuclei
(Fig. 4c). Again, the number of aberrant nuclei was signifi-
cantly increased from 16% in the control cells to over 70%
in the KPNA7-silenced cells (p < 0.01, Fig. 4d). A small
trend towards enlarged nuclear area and YZ aspect ratio
was observed while the XY aspect ratio was significantly
increased (Fig. 4g), thus providing quantitative confirm-
ation on the elongation of the nuclei. Western blot ana-
lysis of the amount of lamin A/C protein showed no
major changes in Hs700T cells but a noticeable decrease
in T-47D cells after KPNA7 silencing (Fig. 5a).
To further assess the impact of KPNA7 depletion on
nuclear structure, immunofluorescent staining of lamin
B1, another major component of the nuclear lamina,
was performed and unveiled radical reorganization and
folding of the protein into the lobules of the nuclei of
Hs700T and T-47D cells (Fig. 6a and b). The flattening
of the Hs700T nuclei in the siKPNA7-treated cells was
again clearly visible. Interestingly, Western blotting
showed that the amount of lamin B1 protein was clearly
increased in the siKPNA7-treated Hs700T cells com-
pared to the corresponding controls whereas no alter-
ations were seen in T-47D cells (Fig. 5b). To evaluate
whether the alterations in nuclear shape are caused by
the activation of contractility of the actin stress fibers,
phosphorylated myosin light chain II (pMLCII) was
immunofluorescently labeled but revealed no radical
changes between the control and siKPNA7-treated cells
in either Hs700T or T-47D cell line (Additional file 5:
Figure S4).
Both the A- and B-type lamins have been shown to inter-
act with nucleoporin 153 (NUP153) [30], one of the com-
ponents of the inner ring of the NPC [31]. Cells depleted
of NUP153 exhibit decreased proliferation and G1 arrest of
the cell cycle, and NUP153 has also been implicated in the
proper organization of nuclear lamina [31]. Immunofluor-
escent staining of NUP153 was carried out to evaluate
whether KPNA7 silencing also influences the number or
localization of the NPCs (Additional file 6: Figure S5A,C).
Quantitative analysis indicated that the KPNA7 silenced
Hs700T cells harbored slightly more NUP153 puncta per
100 μm2 than the control cells (Additional file 6: Figure
S5B). The distribution of NUP153 spots between the apical
and basal sides of the cells was not affected (data not
shown). In T-47D, there were no distinct differences in
NUP153 staining patterns between the siKPNA7 trans-
fected and the control cells (Additional file 6: Figure S5B).
Fig. 3 Mitotic KPNA7-silenced cells exhibit aberrant number of
centrosomes and an abnormal organization of the mitotic spindle.
a Hs700T pancreatic cancer cells and (b) T-47D breast cancer cells
were transfected with either KPNA7 or control LUC siRNA and γ-
tubulin (green) was immunofluorescently labeled 96 h later. Nuclei
were counterstained with DAPI (blue)
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Western blot analysis of the NUP153 protein levels re-
vealed no alterations in the cellular amount of the protein
in either cell line (Additional file 6: Figure S5D).
Discussion
The complex network of proteins comprising the
nuclear transport machinery is a critical player in main-
taining the proper function of eukaryotic cells. In
addition to nuclear transport, these proteins also con-
tribute to other key cellular processes, such as the regu-
lation of cell division [18, 19]. Changes in the functions
of the transport proteins, e.g. due to altered expression
levels, may thus lead to a variety of cellular defects, with
cancer being an ultimate example [9].
In an earlier study, we showed that KPNA7 is an im-
portant regulator of pancreatic cancer cell growth in cell
a b
dc
e f
Fig. 4 KPNA7 is vital for the maintenance of proper nuclear morphology. a Hs700T pancreatic cancer cells and (c) T-47D breast cancer cells were
treated with control (LUC) or KPNA7 siRNA and stained with lamin A/C antibody (green) 96 h post-transfection. The nuclei were counterstained
with DAPI (blue). White squares indicate an individual cell for which an enlarged image is shown and white vertical lines pinpoint the location of
which a cross-section of the nucleus is illustrated. The percentages of normal vs. aberrant nuclei were determined for (b) Hs700T and (d) T-47D
cells from a minimum of six microscopic images. The mean and SD of the replicates are shown. e, f The nuclear area, XY aspect ratio and YZ
aspect ratio were determined from 50 nuclei using the ImageJ software. The median is indicated with a horizontal line. **p < 0.01, ***p < 0.005
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lines harboring amplification and high-level overexpres-
sion of the gene [28]. Moreover, lower levels of KPNA7
expression was detected in cancer cells without amplifi-
cation whereas no or very low level expression expres-
sion was found in normal adult tissues with the
exception of ovary and trachea [28], indicating re-
activation of the gene in cancer cells. This led us to
question whether low level KPNA7 expression also con-
fers a growth benefit to cancer cells. The present study
demonstrates that KPNA7 knock-down consistently
decreased cell growth in all cell lines regardless of the
endogenous expression level, although the most drastic
effect was indeed seen in Hs700T cells with the highest
KPNA7 expression. Furthermore, our data demonstrate
that KPNA7 depletion results in a genuine growth arrest,
as the knock-down cells exhibited minimal or no
proliferation between 72 h and 96 h post-transfection.
These results suggest that even a low amount of KPNA7
yields a growth advantage to cancer cells. In addition,
the growth inhibition phenotype was detected both in
pancreatic and breast cancer cell lines, indicating that
the role of KPNA7 is not limited to pancreatic cancer. A
similar growth regulatory function has been previously
established for KPNA2, which is the closest relative of
KPNA7 and is known to promote cell proliferation in
many malignancies [16, 32–34]. KPNA7 inhibition also
led to alterations in the cell cycle, most notably mani-
festing as decreased fraction of proliferating S-phase
cells, thereby partly explaining the growth defects. This
finding is in accordance with our previous data that
highlighted proteins participating in cell cycle regulation
as KPNA7 cargo candidates [35]. It is thus plausible that
the growth inhibiting effects of KPNA7 silencing are
caused by diminished transport of cell cycle regulators
to the nucleus.
The growth-promoting role and the expression pattern
of KPNA7 makes it an interesting target for the develop-
ment of cancer therapies. Inhibitors against KPNB1 and
Exportin-1, a nuclear export factor of the karyopherin
superfamily, have been tested in different cancers in clin-
ical trials [36]. However, their development has been
hindered by toxicities [36], probably due to their ubiqui-
tous expression and essential function in healthy tissues.
The targeting of KPNA7 would avoid this problem as its
expression is in the current light mainly limited to can-
cer. On the other hand, the high conservation of the
KPNA family members might provide an obstacle for
drug development by creating unspecific effects. As
Kelley et al. reported, KPNA7 is the most divergent
member of the family [23] and might hence represent
the most suitable drug target among the KPNAs. In
addition, recent computational analysis implicated KPNA7
as a potential biomarker for pancreatic cancer [37].
Immunofluorescent analysis of γ-tubulin revealed an
abnormal number of centrosomes and mitotic spindle
poles in a notable fraction of the siKPNA7-treated cells,
with chromatin being pulled by three or more mitotic
spindles towards as many centrosomes. Mislocalization
of the GEF Ran guanine nucleotide exchange factor
(RCC1), which has a key role in maintaining the appro-
priate Ran-GTP gradient, is also known to result in
multipolar spindles [20]. RCC1 has an NLS and it has
been shown to be transported into the nucleus by the
KPNA3 and KPNB1 complex [20]. Our previous study
pinpointed the GEF Ran-binding protein 10 (RANBP10)
as well as multiple other microtubule-associated proteins
as putative KPNA7 cargos [35] and thus their dimin-
ished transport to the nucleus in KPNA7 silenced cells
may contribute to aberrant spindle formation. However,
KPNA7 itself has been shown to localize to the spindle
Fig. 5 KPNA7 depletion induces alterations in the amounts of lamin
proteins. Hs700T and T-47D cells were treated with control or KPNA7
siRNA and Western blotting performed 96 h after transfection with
(a) lamin A/C or (b) lamin B1 antibodies. Tubulin was used as a loading
control. The expression levels were quantitated using ImageJ software
and were normalized against the tubulin loading control. The figures
indicate relative protein expression levels for the siKPNA7 transfected
cells as compared to the corresponding siLUC controls
Fig. 6 KPNA7 silencing causes rearrangement of lamin proteins. a Hs700T
and (b) T-47D cells were treated with control or KPNA7 siRNA and lamin
B1 (green) was immunofluorescently labeled 96 h post-transfection. The
nuclei were counterstained with DAPI (blue). The white squares indicate
an individual cell for which an enlarged image is shown and the white
vertical lines pinpoint the spot for which a cross-section of the nucleus
is illustrated
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structures in murine cells [25], suggesting that it may
also directly influence spindle formation. Moreover,
KPNB1 was demonstrated to regulate the formation of
the spindle via its importin alpha binding (IAB) domain,
further supporting the possible role of karyopherins in
the regulation of spindle formation [38].
KPNA7 depletion also induced distinct changes in the
nuclear morphology in both Hs700T pancreatic and T-
47D breast cancer cells. The nuclear lobulation does not
seem to be fatal for the cells, but may explain the growth
arrest observed. Changes in nuclear shape are usually
attributed to different lamin proteins, i.e. intermediate
filaments that form the nuclear lamina scaffold adjacent
to the inner nuclear membrane [39]. For example, muta-
tions in lamin proteins have been linked to many
diseases known as laminopathies, which are associated
with altered nuclear structure and shape [40]. Lobulated
nuclei, similar to those in KPNA7 depleted Hs700T cells,
are seen in the Hutchinson–Gilford progeria syndrome
(HGPS), which is caused by mutations in lamin A [41].
However, reduction in total amount of lamin B1 has
been reported in HGPS [40] whereas we observed an
increase in lamin B1 protein. Together these data indi-
cate that the mechanisms behind the lobulation of nuclei
are diverse and different alterations in lamin proteins
contribute to this phenomenon.
Lamins A and C confer stiffness to the nuclei, stabiliz-
ing the nucleus against stress, whereas B-type lamins
lend elasticity [42, 43]. The increased amount of lamin
B1 in KPNA7 silenced Hs700T cells is thus likely to ren-
der the nuclear lamina more elastic. This point is sup-
ported by the increased nuclear area, the changed YZ
aspect ratio of the nuclei, and the cross-sectional views
of the lamin protein stainings, all suggesting that the
Hs700T nuclei are flattened after the siKPNA7 treat-
ment. In T-47D cells, no increase in lamin B1 was
detected but lamin A/C amount was decreased. This
might have a similar impact on nuclear rigidity as lamin
B1 increase, since lamin A/C depleted cells show re-
duced nuclear stiffness [43, 44]. The nuclei of the T-47D
cells are relatively flat to begin with, as evidenced by
high YZ aspect ratios, possibly explaining why KPNA7
silencing did not induce similar flattening of the nuclei
as seen in Hs700T but instead resulted in elongated,
elliptical nuclear shape.
Loss of lamin B1 levels have been associated with cel-
lular senescence, a potent tumor-suppressive mechanism
that leads to an irreversible cell cycle exit, and the lamin
B1 loss has also been suggested as a senescence-
associated biomarker [45, 46]. For example, in WI-38
human lung embryonic fibroblast cells, silencing of
lamin B1 induced premature senescence and, vice versa,
the overexpression delayed the onset of senescence [47].
However, in other studies upregulation of lamin B1 has
been linked with induction of senescence [47]. The
current conclusion thus seems to be that the change in
lamin B1 levels is not fully responsible for the senes-
cence phenotype [46, 48]. This notion is in concert with
our previous data [28] showing that the siKPNA7-
treated Hs700T cells, despite the altered lamin B1
amount demonstrated here, do not exhibit senescence-
like characteristics.
It is interesting that the majority (80%) of the
siKPNA7-treated cells exhibited changes in nuclear
morphology, whereas only 20% of the mitotic cells pre-
sented with aberrant multipolar spindles. Based on these
observations one could conclude that the main impact
of KPNA7 depletion is on lamins and nuclear morph-
ology. Nuclear lamins have been shown to play a role in
the formation of the mitotic spindle matrix [49], and
hence the observed aberrant mitosis may be related to
abnormal spindle formation due to the improper func-
tion of the lamins. However, our study does not provide
solid evidence on the chronological sequence of events
between the mitotic defects and altered nuclear morph-
ology, or whether these phenomena are indeed mechan-
istically connected.
Conclusions
In this study, we demonstrate that the silencing of
KPNA7, the least studied member of the karyopherin
alpha family of nuclear transport proteins, leads to a dis-
tinct inhibition of pancreatic and breast cancer cell pro-
liferation, in spite of the endogenous expression level.
Our data also demonstrate that KPNA7 has a critical
role in the regulation of mitosis through the proper
organization of the mitotic spindle and acts in the main-
tenance of the nuclear envelope structure and nuclear
morphology. These results shed new light on the func-
tion of KPNA7 in the regulation of cancer cell growth
and the maintenance of nuclear envelope environment,
and thereby further enhance our knowledge on the role
of nuclear transfer proteins in cancer pathogenesis.
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